
    
      The purpose of the this study was to compare control dose of vitamin D (low dose of 600 IU/d)
      to supplementation dose (medium dose of 2000 IU/d or higher doses of vitamin D of 4000 IU/d)
      on HIV-related comorbidities including immune activation, inflammation, cardiovascular
      diseases, and metabolic complications in HIV-infected youth.
    
  